Watching how depression, bipolar disorder and suicide risk develop in adults receiving care
Observes adults getting clinical care for mood disorders and thoughts of suicide.
Key facts
- Who runs it
- National Institute of Mental Health (NIMH)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Natural History of Depression, Bipolar Disorder and Suicide Risk
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 9 Sept 2024
- Expected to end
- 1 Jun 2030
- Type of study
- Observational, 3 groups
- Record updated
- 9 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are getting care for depression, bipolar disorder or suicide risk. They must also have joined protocol 01-M-0254.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Depression, bipolar disorder or raised suicide risk, under treatment.
Main reasons for not taking part
- Unstable medical conditions that would prevent taking part in outpatient or inpatient treatment
- Pregnancy
- Took part in protocol 01-M-0254 as a healthy volunteer
- Recent substance or alcohol use disorder, or recent use of illicit drugs (caffeine, nicotine and cannabis are treated separately)
- Daily cannabis use, or not being able to stop during the study
The registry criteria, word for word
Show all 9 criteriaShow less
Who cannot take part
- Participants with a history of DSM-IV substance or alcohol abuse or dependence, or DSM-5 substance use disorder (except for caffeine, nicotine, or cannabis), or moderate to severe alcohol use disorder, within the preceding three months. In addition, participants who are currently using drugs (except for caffeine, nicotine, or cannabis) must not have used illicit substances or known drugs of abuse in the two weeks prior to consent and must have a negative drug urine test (except for prescribed benzodiazepines or stimulants) prior to enrolling in the study. Cannabis use is exclusionary if the use is daily, or if participants are unable to abstain during the study, or if function of daily life is impaired by use as determined by a clinician
- Unstable medical conditions in the opinion of the investigator that would preclude participation in outpatient or inpatient treatment
- Participation in the Protocol 01-M-0254: The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers, as a healthy volunteer
- Pregnancy
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Signed consent for Protocol 01-M-0254: The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers
- Age 18 years or older
- Able to provide informed consent
- Able to read and write English
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Elizabeth Ballard, Ph.D.Taking people
About the trial
What the trial wants to find out
Mood disorders, such as depression and bipolar disorder, are difficult to treat. One reason is that there are no objective ways to measure how these disorders affect the body and respond to different treatments. In this study, researchers want to perform tests on people undergoing clinical care for mood disorders. The purpose is to understand the experience of receiving treatment for depression, bipolar disorder, and suicide risk. We also hope that this study will help us to predict which medications will improve thoughts of suicide.
Read full original descriptionShow less
People 18 years or older who are receiving treatment for depression, bipolar disorder, or suicide risk may take part in this study. Participants must have also been enrolled in protocol 01-M-0254.
This study will be conducted at the NIH Clinical Center in Bethesda, MD. The study typically lasts up to 12 weeks, but may last longer if a participant s treatment continues past that time.
Participants will have weekly interviews and questionnaires while they are being treated for their mood disorder. Other tests are optional and include psychological testing, blood draws, sleep tests, and imaging scans. These will be done at the start and the end of research participation.
The 3 groups in the trial
- Bipolar Disorder
Individuals with Bipolar Disorder
- Major Depressive Disorder
Individuals with Major Depressive Disorder
- Suicide Risk
Individuals at an elevated suicide risk
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Natural History of Depression, Bipolar Disorder and Suicide Risk
- Plain-language title
- Watching how depression, bipolar disorder and suicide risk develop in adults receiving careGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06462196, who can take part
- Record updated
- 9 November 2026